THE NEUROPROTECTIVE EFFECT OF BRADYKININ RECEPTOR ANTAGONISTS IN CEREBRAL ISCHEMIA/REPERFUSION RATS

Cui Mei,Dong Qiang,Tang Min,Ren Huimin

DOI: https://doi.org/10.3969/j.issn.1000-7547.2007.01.002

2007-01-01

Abstract:In order to investigate the effect of bradykinin and bradykinin receptor on the permeability of blood-brain barrier (BBB) and secretion of inflammatory factors during the acute phase of cerebral ischemia, the transient middle cerebral artery occlusion (MCAO) model was made following the intraluminal thread technique. Bradykinin B1 or B2 receptor antagonists were administrated immediately after reperfusion. Twenty-four hours after reperfusion, neurological function was appraised by neurological severity scores (NSS), infarct volume was determined by TTC staining, permeability of BBB was measured by Evans blue extravasation, the ultrastructural changes of BBB was observed by transmission electron microscope and the concentrations of IL-1β, TNF-α and PGE2 in ischemic tissues were measured by ELISA. The results showed that bradykinin receptor antagonist can dramatically improve the neurological function, decrease the infarct volume and permeability of BBB, maintain the integrity of BBB, suppress the secretion of inflammatory factors, with a more obvious effect for B2 receptor antagonist. These results suggest that in the acute phase of cerebral ischemia, bradykinin may act as a detrimental factor, whose damage function could be alleviated by its specific receptor antagonists.